anti-obesity medicine
Scope
Date
~
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Osteonic starts sports medicine exports to Japan
South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...
May 19, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Aerospace invests in Israeli startup with anti-jamming tech
South Korea's Hanwha Aerospace Co. has invested in an Israeli start-up possessing anti-jamming technology to prevent interference in global position...
Apr 25, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea wary of tougher US anti-China moves for chipmakers
South Korean President Yoon Suk Yeol on Monday kicked off a six-day state visit to the US with a tough assignment: finding diplomatic solutions for ...
Apr 24, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Ransomware attacks targeting S.Korean companies on sharp rise
Global hacker groups' ransomware attacks against domestic companies and organizations in the first quarter of this year have been revealed to total ...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Celltrion Healthcare launches Vegzelma in US
South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...
Apr 17, 2023 (Gmt+09:00)
-
Energy
Korea’s small nuclear reactor technology falls behind global peers
South Korea’s small-sized nuclear reactor technology has fallen behind other major countries due to the years of the previous government&rsquo...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs, Kakao Healthcare to explore microbiome-based precision medicine solutions
Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
CGBio inks export deal for hyaluronic acid fillers with Chinese distributor
CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...
Mar 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, Axiom Space to set up JV to explore space healthcare options
South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...
Mar 21, 2023 (Gmt+09:00)
-
Chemical Industry
Noroo Paint, GS E&C jointly develop anti-carbonation paint for concrete
Noroo Paint, in collaboration with GS Engineering & Construction Co., announced on Tuesday the development of "Qfit Protect," a high-performance...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem mulls shuttering in-vitro diagnostics business
LG Chem Ltd. is considering an exit from the in-vitro diagnostics market to focus more on novel drug development as it lagged its smaller local riva...
Mar 13, 2023 (Gmt+09:00)
-
ESG
SKC earns ISO 37001 certification for anti-corruption management
SKC, the chemical materials unit of South Korea's second-largest conglomerate, announced on Thursday that it has received the ISO 37001 certificatio...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 to work with Romanian state-run defense supplier
South Korea's defense contractor LIG Nex1 Co. will join hands with ROMARM, a Romanian state-run defense company, to develop anti-aircraft missiles a...
Feb 09, 2023 (Gmt+09:00)
-
IPOs
S.Korea's InnoGene sets its public offering price at 3,000 won
InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea's top sci-tech school creates cutting-edge anti-drone technology
A research team at South Korea's top science and technology university has developed an anti-drone technology that can remotely neutralize a city-in...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Ybrain, Chong Kun Dang join forces for digital medicine distribution
South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand